Literature DB >> 2612548

Penetration of cyclosporin into synovial fluid in rheumatoid arthritis.

A W van Rijthoven1, B A Dijkmans, H S Goei Thè, M Boers, A Cats.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2612548     DOI： 10.1007/bf00679794

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  8 in total

1.  Cyclosporin. Mechanism of action: in vitro studies.

Authors:  A D Hess; P M Colombani
Journal:  Prog Allergy       Date:  1986

2.  Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study.

Authors:  A W van Rijthoven; B A Dijkmans; H S Goei The; J Hermans; Z L Montnor-Beckers; P C Jacobs; A Cats
Journal:  Ann Rheum Dis       Date:  1986-09       Impact factor: 19.103

3.  Cyclosporin A in rheumatoid arthritis: preliminary clinical results of an open trial.

Authors:  M Dougados; B Amor
Journal:  Arthritis Rheum       Date:  1987-01

4.  Cyclosporin A treatment of refractory rheumatoid arthritis.

Authors:  M E Weinblatt; J S Coblyn; P A Fraser; R J Anderson; J Spragg; D E Trentham; K F Austen
Journal:  Arthritis Rheum       Date:  1987-01

5.  An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: a preliminary report.

Authors:  O Førre; F Bjerkhoel; C F Salvesen; K J Berg; H E Rugstad; G Saelid; O J Mellbye; E Kåss
Journal:  Arthritis Rheum       Date:  1987-01

6.  Intravenous cyclosporine kinetics in renal failure.

Authors:  F Follath; M Wenk; S Vozeh; G Thiel; F Brunner; R Loertscher; M Lemaire; K Nussbaumer; W Niederberger; A Wood
Journal:  Clin Pharmacol Ther       Date:  1983-11       Impact factor: 6.875

7.  A radioimmunoassay to measure cyclosporin A in plasma and serum samples.

Authors:  P Donatsch; E Abisch; M Homberger; R Traber; M Trapp; R Voges
Journal:  J Immunoassay       Date:  1981

8.  Low dose cyclosporine in rheumatoid arthritis: a pilot study.

Authors:  P Tugwell; C Bombardier; M Gent; K Bennett; D Ludwin; E Grace; W W Buchanan; W G Bensen; N Bellamy; G F Murphy
Journal:  J Rheumatol       Date:  1987-12       Impact factor: 4.666
  8 in total
  1 in total

Review 1.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.